Correspondence 0001104659-24-100172 from Zura Bio Ltd (ZURA)
Zura Bio Ltd
Date: Sept. 16, 2024 · CIK: 0001855644 · Accession: 0001104659-24-100172
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281905
Letter
Zura Bio Limited
1489 W. Warm Springs Rd. #110
Henderson, NV 89014
September 16, 2024
VIA EDGAR
Division of Corporation Finance
Office of Technology
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
RE: Zura Bio Limited
Registration Statement on Form S-3
File No. 333-281905
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, Zura Bio Limited (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on September 17, 2024, at 9:00 a.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Divakar Gupta, Sarah Sellers and Brandon Fenn of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Sarah Sellers of Cooley LLP, counsel to the Registrant, at (212) 479-6370, or in her absence, Brandon Fenn at (212) 479-6626.
Very truly yours,
ZURA BIO LIMITED
Show Raw Text
CORRESP
1
filename1.htm
Zura Bio Limited
1489 W. Warm Springs Rd. #110
Henderson, NV 89014
September 16, 2024
VIA EDGAR
Division of Corporation Finance
Office of Technology
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
RE:
Zura Bio Limited
Registration Statement on Form S-3
File No. 333-281905
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Exchange
Act of 1933, as amended, Zura Bio Limited (the “Registrant”) hereby requests that the U.S. Securities and Exchange
Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to
become effective on September 17, 2024, at 9:00 a.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the
Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Divakar Gupta,
Sarah Sellers and Brandon Fenn of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared
effective, please orally confirm that event with Sarah Sellers of Cooley LLP, counsel to the Registrant, at (212) 479-6370, or in
her absence, Brandon Fenn at (212) 479-6626.
Very truly yours,
ZURA BIO LIMITED
By:
/s/ Verender Badial
Name:
Verender Badial
Title:
Chief Financial Officer
cc:
Kim Davis, Zura Bio Limited
Divakar Gupta, Cooley LLP
Sarah Sellers, Cooley LLP
Brandon Fenn, Cooley LLP